Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chufeng Zhang

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|January 3, 2024
Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitorsChufeng Zhang, Yulian Chen, Yong Li, et al.
Journal of Medicinal Chemistry|February 17, 2021
Discovery of 3-(4-(2-((1<i>H</i>-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1<i>H</i>-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel DiseaseChufeng Zhang, Wenyan Qi, Yong Li, et al.
European Journal of Medicinal Chemistry|March 2, 2024
Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agentsChufeng Zhang, Wei Yan, Yan Liu, et al.
European Journal of Medicinal Chemistry|January 12, 2018
Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritisLinhong He, Heying Pei, Chufeng Zhang, et al.
Angewandte Chemie (International Ed. in English)|October 23, 2019
Unpaired 3d Electrons on Atomically Dispersed Cobalt Centres in Coordination Polymers Regulate both Oxygen Reduction Reaction (ORR) Activity and Selectivity for Use in Zinc-Air BatteriesYuebin Lian, Wenjuan Yang, Chufeng Zhang, et al.
European Journal of Medicinal Chemistry|November 26, 2025
Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapyChufeng Zhang, Yulian Chen, Minghai Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2025
Identification of a ligand-binding site on tubulin mediating the tubulin-RB3 interactionYong Li, Chufeng Zhang, Dongmei Tang, et al.
European Journal of Medicinal Chemistry|October 17, 2025
Structure-based design and synthesis of 3-substituted-1,2,4-triazolo[1,5-a]pyrimidines as dual vinca/gatorbulin-site ligands for cancer treatmentChufeng Zhang, Wei Yan, Hongxiu Chen, et al.
Journal of Medicinal Chemistry|June 16, 2022
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)Xue Yuan, Yong Chen, Minghai Tang, et al.
European Journal of Medicinal Chemistry|February 29, 2024
Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancerYaxin Teng, Rui Wu, Weichen Bo, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|January 3, 2024
Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitorsChufeng Zhang, Yulian Chen, Yong Li, et al.
Journal of Medicinal Chemistry|February 17, 2021
Discovery of 3-(4-(2-((1<i>H</i>-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1<i>H</i>-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel DiseaseChufeng Zhang, Wenyan Qi, Yong Li, et al.
European Journal of Medicinal Chemistry|March 2, 2024
Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agentsChufeng Zhang, Wei Yan, Yan Liu, et al.
European Journal of Medicinal Chemistry|January 12, 2018
Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritisLinhong He, Heying Pei, Chufeng Zhang, et al.
Angewandte Chemie (International Ed. in English)|October 23, 2019
Unpaired 3d Electrons on Atomically Dispersed Cobalt Centres in Coordination Polymers Regulate both Oxygen Reduction Reaction (ORR) Activity and Selectivity for Use in Zinc-Air BatteriesYuebin Lian, Wenjuan Yang, Chufeng Zhang, et al.
European Journal of Medicinal Chemistry|November 26, 2025
Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapyChufeng Zhang, Yulian Chen, Minghai Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2025
Identification of a ligand-binding site on tubulin mediating the tubulin-RB3 interactionYong Li, Chufeng Zhang, Dongmei Tang, et al.
European Journal of Medicinal Chemistry|October 17, 2025
Structure-based design and synthesis of 3-substituted-1,2,4-triazolo[1,5-a]pyrimidines as dual vinca/gatorbulin-site ligands for cancer treatmentChufeng Zhang, Wei Yan, Hongxiu Chen, et al.
Journal of Medicinal Chemistry|June 16, 2022
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)Xue Yuan, Yong Chen, Minghai Tang, et al.
European Journal of Medicinal Chemistry|February 29, 2024
Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancerYaxin Teng, Rui Wu, Weichen Bo, et al.
Pageof 5